Osteoporosis Clinical Trial
— SAOSOfficial title:
Stop At One Stockholm: Co-operation Between Health Care Providers and Medical Education in Primary Health Care to Prevent Falls and Fractures in the Elderly
Verified date | April 2024 |
Source | Karolinska Institutet |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a study on the effects of education on secondary fracture prevention in primary health care centers (PHCC) and referral from hospitals to these PHCC of patients with recent fragility fractures. The design is Cluster-randomized controlled study with two arms. 40 primary health care centers (PHCC) are included, each PHCC constitutes a cluster. The intervention group contains 20 PHCCs and the control group of the remaining 20 PHCCs. The educational part of the intervention is divided into three sessions; one web based course succeeded by two multiprofessional seminars with six months interval. During the intervention period patients enlisted at the intervention PHCCs, aged 60 or more who are diagnosed on a fragility fracture are referred to their respective PHCC. The primary outcome are the proportions of patients who receive bone specific treatment after their fracture in the intervention group compared to the control group.
Status | Active, not recruiting |
Enrollment | 3600 |
Est. completion date | June 2027 |
Est. primary completion date | June 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years and older |
Eligibility | All primary health care centers (PHCCs) in Stockholm County were invited to participate in the study. The goal was to include at least 40 Inclusion Criteria for referral of patients to PHCC: - Patient has a diagnose at a medical care unit within Stockholm county on a low energy fracture of hip, pelvis, spine, proximal humerus och distal radius between three months before study start an end of study. - Patient is enlisted at one of the PHCCs in the interventional arm of the study - Patent is aged 60 years or older Exclusion Criteria: - The patient has after the index fracture, already been referred to the correct primary health care center for secondary fracture prevention. |
Country | Name | City | State |
---|---|---|---|
Sweden | Karolinska Instititet | Huddinge | Stockholm |
Lead Sponsor | Collaborator |
---|---|
Helena Salminen | Region Stockholm |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Incidence of new fractures and fall related injuries after index fracture. | Participants are included in the study at the date of their first fragility fracture within the study period. Mortality, fractures and other fall related injuries are collected from National health care registers for the period three and five years after the last patient was included in the study. The follow up time will thus be different for different participants depending on the date of inclusion. | Three and sive years after last participant was included, | |
Primary | Proportion of participants treated with bone specific drugs after first fragility fracture at different points in time up to three years after inclusion. | Participants are included in the study at the date of their first fragility fracture within the study period. The proportion of participants treated with bone-specific drugs any time since the fracture date, will be measured every 6 months during the study period. | Three years after inclusion of study participant | |
Secondary | Proportion of participants treated with calcium and vitamin D but not bone specific drugs after first fragility fracture at different points in time after inclusion up to three years after inclusion. | Participants are included in the study at the date of their first fragility fracture within the study period. The proportion of participants treated with Calcium and vitamin D supplements but not simultaneously with bone-specific drugs at any time since the fracture date, will be measured until three years after inclusion. | Three years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06287502 -
Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis
|
N/A | |
Completed |
NCT03822078 -
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
|
Phase 1 | |
Recruiting |
NCT05845021 -
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
|
N/A | |
Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
Completed |
NCT04736693 -
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
|
||
Not yet recruiting |
NCT06431867 -
Primary Care Management of Osteoporosis in Older Women
|
||
Completed |
NCT02922478 -
Role of Comorbidities in Chronic Heart Failure Study
|
||
Recruiting |
NCT02616627 -
Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
|
||
Recruiting |
NCT02635022 -
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
|
||
Active, not recruiting |
NCT02617303 -
Prevention of Falls and Its Consequences in Elderly People
|
N/A | |
Completed |
NCT02566655 -
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
|
Phase 1 | |
Completed |
NCT03420716 -
Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women
|
N/A | |
Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
Completed |
NCT02559648 -
Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis
|
Phase 2 | |
Not yet recruiting |
NCT01854086 -
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
|
N/A | |
Unknown status |
NCT01913834 -
Nasally and sc Administered Teriparatide in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02003716 -
DeFRA Questionnaire as an Anamnestic Form
|
N/A | |
Completed |
NCT02143674 -
Muscle Strengthening Exercises and Global Stretching in Elderly
|
N/A | |
Completed |
NCT01757340 -
Calorie Restriction With Leucine Supplementation
|
N/A |